{"entity":{"type":"insider","cik":"0001559512","url":"/insider/0001559512","json_url":"/insider/0001559512.json","name":"Adorini Luciano","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":64,"n_filings":16,"first":"2013-06-24","last":"2015-07-08","span_basis":"filed_date"},"name_variants":[{"name":"Adorini Luciano","source":"filing","n_filings":16,"first_seen":"2013-06-24","last_seen":"2015-07-08"}],"transactions":[{"id":8298520,"accession":"0001144204-15-041689","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0001144204-15-041689","line_url":"/filing/0001144204-15-041689","is_derivative":false,"issuer_cik":"0001270073","issuer_name":"INTERCEPT PHARMACEUTICALS INC","issuer_ticker":"ICPT","issuer_name_source":null,"issuer_url":"/issuer/0001270073","owner_cik":"0001559512","owner_name":"Adorini Luciano","owner_display_name":"Adorini Luciano","owner_url":"/insider/0001559512","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4067.0,"shares_display":"4,067","price_per_share":579.9339592820261,"price_display":"579.93","price_state":"stated","total_value":2358591.4124,"total_display":"2,358,591.41","total_whole":"2,358,591","shares_owned_after":12609.0,"shares_owned_after_display":"12,609","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-07-06","filed_date":"2015-07-08","scope":"insider","n_lines":6},{"id":8843137,"accession":"0001144204-15-036564","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001144204-15-036564","line_url":"/filing/0001144204-15-036564","is_derivative":false,"issuer_cik":"0001270073","issuer_name":"INTERCEPT PHARMACEUTICALS INC","issuer_ticker":"ICPT","issuer_name_source":null,"issuer_url":"/issuer/0001270073","owner_cik":"0001559512","owner_name":"Adorini Luciano","owner_display_name":"Adorini Luciano","owner_url":"/insider/0001559512","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4000.0,"shares_display":"4,000","price_per_share":248.39955,"price_display":"248.40","price_state":"stated","total_value":993598.2,"total_display":"993,598.20","total_whole":"993,598","shares_owned_after":10060.0,"shares_owned_after_display":"10,060","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-06-08","filed_date":"2015-06-10","scope":"insider","n_lines":2},{"id":8647680,"accession":"0001144204-15-028941","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001144204-15-028941","line_url":"/filing/0001144204-15-028941","is_derivative":false,"issuer_cik":"0001270073","issuer_name":"INTERCEPT PHARMACEUTICALS INC","issuer_ticker":"ICPT","issuer_name_source":null,"issuer_url":"/issuer/0001270073","owner_cik":"0001559512","owner_name":"Adorini Luciano","owner_display_name":"Adorini Luciano","owner_url":"/insider/0001559512","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4000.0,"shares_display":"4,000","price_per_share":259.9657,"price_display":"259.97","price_state":"stated","total_value":1039862.8,"total_display":"1,039,862.80","total_whole":"1,039,863","shares_owned_after":12260.0,"shares_owned_after_display":"12,260","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-05-06","filed_date":"2015-05-08","scope":"insider","n_lines":4},{"id":8810028,"accession":"0001144204-15-021900","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001144204-15-021900","line_url":"/filing/0001144204-15-021900","is_derivative":false,"issuer_cik":"0001270073","issuer_name":"INTERCEPT PHARMACEUTICALS INC","issuer_ticker":"ICPT","issuer_name_source":null,"issuer_url":"/issuer/0001270073","owner_cik":"0001559512","owner_name":"Adorini Luciano","owner_display_name":"Adorini Luciano","owner_url":"/insider/0001559512","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4000.0,"shares_display":"4,000","price_per_share":269.6425,"price_display":"269.64","price_state":"stated","total_value":1078570.0,"total_display":"1,078,570.00","total_whole":"1,078,570","shares_owned_after":10060.0,"shares_owned_after_display":"10,060","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-04-06","filed_date":"2015-04-08","scope":"insider","n_lines":3},{"id":6200083,"accession":"0001144204-14-050900","txn_seq":28,"anchor":"line-28","filing_url":"/filing/0001144204-14-050900","line_url":"/filing/0001144204-14-050900","is_derivative":false,"issuer_cik":"0001270073","issuer_name":"INTERCEPT PHARMACEUTICALS INC","issuer_ticker":"ICPT","issuer_name_source":null,"issuer_url":"/issuer/0001270073","owner_cik":"0001559512","owner_name":"Adorini Luciano","owner_display_name":"Adorini Luciano","owner_url":"/insider/0001559512","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":11038.0,"shares_display":"11,038","price_per_share":321.62330951259287,"price_display":"321.62","price_state":"stated","total_value":3550078.0904,"total_display":"3,550,078.09","total_whole":"3,550,078","shares_owned_after":15051.0,"shares_owned_after_display":"15,051","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-08-12","filed_date":"2014-08-15","scope":"insider","n_lines":27},{"id":7100055,"accession":"0001144204-14-029234","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001144204-14-029234","line_url":"/filing/0001144204-14-029234","is_derivative":false,"issuer_cik":"0001270073","issuer_name":"INTERCEPT PHARMACEUTICALS INC","issuer_ticker":"ICPT","issuer_name_source":null,"issuer_url":"/issuer/0001270073","owner_cik":"0001559512","owner_name":"Adorini Luciano","owner_display_name":"Adorini Luciano","owner_url":"/insider/0001559512","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2000.0,"shares_display":"2,000","price_per_share":259.4376,"price_display":"259.44","price_state":"stated","total_value":518875.2,"total_display":"518,875.20","total_whole":"518,875","shares_owned_after":7464.0,"shares_owned_after_display":"7,464","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-05-07","filed_date":"2014-05-09","scope":"insider","n_lines":2},{"id":6487879,"accession":"0001144204-14-021706","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001144204-14-021706","line_url":"/filing/0001144204-14-021706","is_derivative":false,"issuer_cik":"0001270073","issuer_name":"INTERCEPT PHARMACEUTICALS INC","issuer_ticker":"ICPT","issuer_name_source":null,"issuer_url":"/issuer/0001270073","owner_cik":"0001559512","owner_name":"Adorini Luciano","owner_display_name":"Adorini Luciano","owner_url":"/insider/0001559512","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2000.0,"shares_display":"2,000","price_per_share":283.9,"price_display":"283.90","price_state":"stated","total_value":567800.0,"total_display":"567,800.00","total_whole":"567,800","shares_owned_after":7041.0,"shares_owned_after_display":"7,041","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-04-07","filed_date":"2014-04-09","scope":"insider","n_lines":3},{"id":6475427,"accession":"0001144204-14-014961","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001144204-14-014961","line_url":"/filing/0001144204-14-014961#line-2","is_derivative":false,"issuer_cik":"0001270073","issuer_name":"INTERCEPT PHARMACEUTICALS INC","issuer_ticker":"ICPT","issuer_name_source":null,"issuer_url":"/issuer/0001270073","owner_cik":"0001559512","owner_name":"Adorini Luciano","owner_display_name":"Adorini Luciano","owner_url":"/insider/0001559512","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2000.0,"shares_display":"2,000","price_per_share":421.31,"price_display":"421.31","price_state":"stated","total_value":842620.0,"total_display":"842,620.00","total_whole":"842,620","shares_owned_after":6392.0,"shares_owned_after_display":"6,392","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-03-07","filed_date":"2014-03-11","scope":"insider"},{"id":6378408,"accession":"0001144204-14-007722","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001144204-14-007722","line_url":"/filing/0001144204-14-007722#line-4","is_derivative":false,"issuer_cik":"0001270073","issuer_name":"INTERCEPT PHARMACEUTICALS INC","issuer_ticker":"ICPT","issuer_name_source":null,"issuer_url":"/issuer/0001270073","owner_cik":"0001559512","owner_name":"Adorini Luciano","owner_display_name":"Adorini Luciano","owner_url":"/insider/0001559512","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1000.0,"shares_display":"1,000","price_per_share":301.78,"price_display":"301.78","price_state":"stated","total_value":301780.0,"total_display":"301,780.00","total_whole":"301,780","shares_owned_after":7392.0,"shares_owned_after_display":"7,392","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-02-07","filed_date":"2014-02-11","scope":"insider"},{"id":6378406,"accession":"0001144204-14-007722","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001144204-14-007722","line_url":"/filing/0001144204-14-007722#line-3","is_derivative":false,"issuer_cik":"0001270073","issuer_name":"INTERCEPT PHARMACEUTICALS INC","issuer_ticker":"ICPT","issuer_name_source":null,"issuer_url":"/issuer/0001270073","owner_cik":"0001559512","owner_name":"Adorini Luciano","owner_display_name":"Adorini Luciano","owner_url":"/insider/0001559512","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":500.0,"shares_display":"500","price_per_share":310.04,"price_display":"310.04","price_state":"stated","total_value":155020.0,"total_display":"155,020.00","total_whole":"155,020","shares_owned_after":6392.0,"shares_owned_after_display":"6,392","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-02-07","filed_date":"2014-02-11","scope":"insider"}],"collapsed":true,"next_cursor":"2014-02-07|6378406","ledger_fault":false,"count":{"value":64,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":64,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":64},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001270073","name":"INTERCEPT PHARMACEUTICALS INC","url":"/issuer/0001270073","role":"Officer (Chief Scientific Officer)","n_filings":16,"first_seen":"2013-06-24","last_seen":"2015-07-08"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001559512","retrieved_at":"2026-08-25T18:09:51+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-24","last_ingest":"2026-08-25T05:24:19.374141+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}